We have previously described a strategy for detecting protein–protein interactions based on protein interaction–assisted folding of rationally designed fragments of enzymes. We call this strategy the protein fragment complementation assay (PCA)1,2,3,4,5. Here we describe PCAs based on the enzyme TEM-1 β-lactamase (EC: 18.104.22.168), which include simple colorimetric in vitro assays using the cephalosporin nitrocefin and assays in intact cells using the fluorescent substrate CCF2/AM (ref. 6). Constitutive protein–protein interactions of the GCN4 leucine zippers and of apoptotic proteins Bcl2 and Bad, and the homodimerization of Smad3, were tested in an in vitro assay using cell lysates. With the same in vitro assay, we also demonstrate interactions of protein kinase PKB with substrate Bad. The in vitro assay is facile and amenable to high-throughput modes of screening with signal-to-background ratios in the range of 10:1 to 250:1, which is superior to other PCAs developed to date. Furthermore, we show that the in vitro assay can be used for quantitative analysis of a small molecule–induced protein interaction, the rapamycin-induced interaction of FKBP and yeast FRB (the FKBP-rapamycin binding domain of TOR (target of rapamycin)). The assay reproduces the known dissociation constant and number of sites for this interaction. The combination of in vitro colorimetric and in vivo fluorescence assays of β-lactamase in mammalian cells suggests a wide variety of sensitive and high-throughput large-scale applications, including in vitro protein array analysis of protein–protein or enzyme–protein interactions and in vivo applications such as clonal selection for cells expressing interacting protein partners.
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $20.83 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
We are grateful to F.-X. C.-Valois for valuable insights and suggestions, Ingrid Remy, Annie Montmarquette, and Galia Ghaddar for protein fusion constructs, and Claudia Jomphe for aid with microscopic imaging experiments. We thank Roger Tsien (University of California at San Diego) for supplying us with CCF2/AM. This research was supported by the Burroughs-Wellcome Fund (BWF) and the Canadian Institutes of Health Research (MOP82008 to S.W.M.; MOP4959 to L.-E. T.). A.G. is a recipient of a doctoral fellowship from the Fonds pour la Formation de Chercheurs et l'Aide à la Recherche. S.W.M. is a Medical Research Council of Canada Scientist and holds a Canada Research Chair. L.-E. T. is a EJLB Foundation Scholar and a Michael Smith Scholar of the Canadian Institutes of Health Research.